Product Information
ALLERGY MULTI-SYMPTOM CAPLET is a generic product labeled by Cardinal Health, priced at $0.0863 per EA under NDC 70000021101. Its NADAC has been published 465 times since Nov 8, 2017.
Strength
325; 2; 5 mg/1; mg/1; mg/1
Manufacturer
Cardinal HealthNDC
70000021101
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDEApproval Type
OTC MONOGRAPH DRUG
FDA Application
M012On Market Since
6/28/2005
Pharmacological Classes
Price Statistics
The NADAC for ALLERGY MULTI-SYMPTOM CAPLET has been published 465 times since Nov 8, 2017, and over the history we have for it it has risen 4.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0863 per EA |
|---|---|
| All-time high | $0.0939 (Apr 10, 2024) |
| All-time low | $0.0622 (Feb 19, 2020) |
| 52-week high | $0.0887 |
| 52-week low | $0.0828 |
| Median price | $0.0769 |
| Average price | $0.0758 |
| Largest weekly change | +14.4% (Jul 20, 2022) |
| Weeks tracked | 465 |
| Tracking since | Nov 8, 2017 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Acetaminophen, Chlorpheniramine Maleate, Phenylephrine HCl market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Cardinal Health manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Acetaminophen, Chlorpheniramine Maleate, Phenylephrine HCl market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Histamine-1 Receptor Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ALLERGY MULTI-SYMPTOM CAPLET?
The current National Average Drug Acquisition Cost (NADAC) for ALLERGY MULTI-SYMPTOM CAPLET, manufactured by Cardinal Health, is $0.0863 per EA (NDC 70000021101), effective Sep 30, 2026.
How has the price of ALLERGY MULTI-SYMPTOM CAPLET changed over time?
Over the history we have for it, the NADAC for ALLERGY MULTI-SYMPTOM CAPLET has risen 4.6%. It has been tracked across 465 weekly CMS publications since Nov 8, 2017.
What are the highest and lowest recorded NADAC prices for ALLERGY MULTI-SYMPTOM CAPLET?
Since Nov 8, 2017, the NADAC for ALLERGY MULTI-SYMPTOM CAPLET has ranged from a low of $0.0622 (Feb 19, 2020) to a high of $0.0939 (Apr 10, 2024), with a median of $0.0769 per EA.
Are there cheaper alternatives to ALLERGY MULTI-SYMPTOM CAPLET?
No other NADAC-published product currently shares the active ingredient and strength of ALLERGY MULTI-SYMPTOM CAPLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures ALLERGY MULTI-SYMPTOM CAPLET?
ALLERGY MULTI-SYMPTOM CAPLET (NDC 70000021101) is labeled by Cardinal Health, and CMS classifies it as a generic product.